BridGene Biosciences names David Sperandio, Ph.D., as Head of Chemistry
- Monday, August 1, 2022, 7:00
- Finance
- Add a comment
SAN JOSE, Calif., Aug. 1, 2022 /PRNewswire/ — BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high value, traditionally undruggable targets, today announced that David Sperandio, Ph.D., a…
About the Author
adminasapcorp has written 38955 stories on this site.